» Articles » PMID: 1618678

Recurrent Locally Advanced Nasopharyngeal Carcinoma Treated with Heavy Charged Particle Irradiation

Overview
Specialties Oncology
Radiology
Date 1992 Jan 1
PMID 1618678
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Between June 1981 and May 1990, 11 patients with recurrent locally advanced nasopharyngeal carcinoma were treated with heavy charged particle radiation at Lawrence Berkeley Laboratory. All patients had previously undergone full course radiotherapy to a median dose of 70.2 Gy [range 61-81 Gy]. Median time to recurrence was 18.2 months. At the time of heavy charged particle radiotherapy treatment, all had evidence of invasion of the base of skull and 7 of 11 had cranial nerve deficits. None of the patients were candidates for brachytherapy because of tumor extent or poor geometry. The tumor histology was squamous cell carcinoma in 10 patients and lymphoepithelioma in one patient. Ten of the 11 patients had received chemotherapy prior to re-irradiation. The heavy charged particle tumor dose delivered ranged from 31.80 GyE to 62.30 GyE (average 50.25 GyE, median 50 GyE). Local control was achieved in 45%. Median survival was 42 months. Actuarial survival was 59% at 3 years and 31% at 5 years (Kaplan-Meier). There were no fatal complications. The results in treating locally advanced recurrent nasopharyngeal carcinoma with heavy charged particles appear superior to those reported by others using photon therapy.

Citing Articles

A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors.

Gamez M, Patel S, McGee L, Sio T, McDonald M, Phan J Int J Part Ther. 2021; 8(1):131-154.

PMID: 34285942 PMC: 8270105. DOI: 10.14338/IJPT-20-00064.1.


Nasopharyngeal carcinoma: an evolving paradigm.

Wong K, Hui E, Lo K, Lam W, Johnson D, Li L Nat Rev Clin Oncol. 2021; 18(11):679-695.

PMID: 34194007 DOI: 10.1038/s41571-021-00524-x.


RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model.

Zhang L, Wang W, Hu J, Lu J, Kong L Radiat Oncol. 2020; 15(1):277.

PMID: 33302998 PMC: 7731771. DOI: 10.1186/s13014-020-01723-z.


Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.

Hu J, Huang Q, Gao J, Guan X, Hu W, Yang J Cancer. 2020; 126(23):5173-5183.

PMID: 32931035 PMC: 7693227. DOI: 10.1002/cncr.33197.


Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility.

Blakely E, Faddegon B, Tinkle C, Bloch C, Dominello M, Griffin R J Appl Clin Med Phys. 2019; 20(11):6-13.

PMID: 31573146 PMC: 6839391. DOI: 10.1002/acm2.12727.